{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:15:25Z","timestamp":1781882125794,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.eprac.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T16:13:41Z","timestamp":1725293621000},"page":"1066-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-3130","authenticated-orcid":false,"given":"Daniel J.","family":"Slack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix G.","family":"Contreras-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Safer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2024.08.014_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/trgh.2020.0094","article-title":"The effect of gender-affirming hormones on gender dysphoria, quality of life, and psychological functioning in transgender individuals: a systematic review","volume":"8","author":"van Leerdam","year":"2023","journal-title":"Transgender Health"},{"key":"10.1016\/j.eprac.2024.08.014_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.717766","article-title":"Short-term effects of gender-affirming hormone therapy on dysphoria and quality of life in transgender individuals: a prospective controlled study","volume":"12","author":"Foster Skewis","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eprac.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-018-0973-0","article-title":"Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr Psychiatr Rep"},{"issue":"11","key":"10.1016\/j.eprac.2024.08.014_bib4","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.08.014_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"4","key":"10.1016\/j.eprac.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.eprac.2024.08.014_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.eprac.2024.08.014_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0049-3848(00)00217-6","article-title":"The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of the literature","volume":"99","author":"Douketis","year":"2000","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.eprac.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.eprac.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eprac.2024.08.014_bib11","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.eprac.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/jth.15256","article-title":"Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen","volume":"19","author":"Scheres","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.eprac.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.eprac.2024.08.014_bib14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2024.08.014_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.741866","article-title":"Risk of venous thromboembolism in transgender people undergoing hormone feminizing therapy: a prevalence meta-analysis and meta-regression study","volume":"12","author":"Totaro","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2024.08.014_bib16","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.eprac.2024.08.014_bib17","first-page":"209","article-title":"Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy","volume":"10","author":"Goldstein","year":"2019","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.eprac.2024.08.014_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100154","article-title":"Accuracy of venous thromboembolism ICD-10 codes: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2024","journal-title":"Thrombosis Update"},{"issue":"2","key":"10.1016\/j.eprac.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/03009742.2021.2001907","article-title":"Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis","volume":"52","author":"Molander","year":"2023","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.eprac.2024.08.014_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/a-0588-4736","volume":"81","author":"Angelow","year":"2019","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.eprac.2024.08.014_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/1178222616685880","article-title":"Using electronic medical record to identify patients with dyslipidemia in primary care settings: International Classification of Disease Code matters from one region to a national database","volume":"9","author":"Oake","year":"2017","journal-title":"Biomed Inform Insights"},{"key":"10.1016\/j.eprac.2024.08.014_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/CLEP.S353435","article-title":"Validation of stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage on Taiwan's National Health Insurance claims data","volume":"14","author":"Hsieh","year":"2022","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.eprac.2024.08.014_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000547","article-title":"Validity of ICD-10-CM codes for determination of diabetes type for persons with youth-onset type 1 and type 2 diabetes","volume":"7","author":"Chi","year":"2019","journal-title":"BMJ Open Diabetes Research Care"},{"issue":"2","key":"10.1016\/j.eprac.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.diabres.2010.03.007","article-title":"Validating ICD coding algorithms for diabetes mellitus from administrative data","volume":"89","author":"Chen","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2024.08.014_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12913-024-10685-x","article-title":"Validation of human immunodeficiency virus diagnosis codes among women enrollees of a U.S. health plan","volume":"24","author":"Pocobelli","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.eprac.2024.08.014_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjmed.2019.03.021","article-title":"Reasons for differences in the incidence of venous thromboembolism in Black versus White Americans","volume":"132","author":"Folsom","year":"2019","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.eprac.2024.08.014_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2010.01.057","article-title":"Risk factors for venous thromboembolism","volume":"56","author":"Goldhaber","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.eprac.2024.08.014_bib28","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A\u00a0comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.eprac.2024.08.014_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eprac.2021.03.010","article-title":"Minimizing venous thromboembolism in feminizing hormone therapy: applying lessons from cisgender women and previous data","volume":"27","author":"Zucker","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2024.08.014_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/AOG.0b013e318277c93b","article-title":"Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Committee Opinion No. 540","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eprac.2024.08.014_bib31","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"issue":"9382","key":"10.1016\/j.eprac.2024.08.014_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eprac.2024.08.014_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e32833c07bc","article-title":"Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women","volume":"17","author":"Oli\u00e9","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"10.1016\/j.eprac.2024.08.014_bib34","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/jc.2015-2237","article-title":"Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis","volume":"100","author":"Mohammed","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:44:24Z","timestamp":1730508264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1530891X24006633"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.08.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}